The global immunotherapy market is rapidly evolving as technological, regulatory, and economic trends combine to alter the growth and risk dynamics within the industry.
UroGen Pharma Ltd. (NASDAQ:NASDAQ:URGN) Q1 2022 Earnings Conference Call May 10, 2022, 10:00 AM ET Company Participants Vincent Perrone - Senior Director of IR Liz Barrett - President and.
Insmed Inc. (NASDAQ:NASDAQ:INSM) Q1 2022 Results Conference Call May 05, 2022 08:30 AM ET Company Participants Eleanor Barisser - IR Will Lewis - Chairman, CEO Sara Bonstein - CFO.